[ Price : $8.95]
Five stakeholders suggest possible topics for an upcoming FDA workshop on innovative drug clinical trials.[ Price : $8.95]
Twenty-eight non-profit groups representing the CBD (cannabidiol) and hemp industries call on Congress to hold a hearing to unders...[ Price : $8.95]
FDA publishes an updated guidance incorporating GDUFA 3 performance goals on amendments and requests for final approval to tentati...[ Price : $8.95]
FDA sends Theratechnologies a complete response letter on its supplemental BLA for an F8 formulation of Egrifta SV (tesamorelin), ...[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection extension entitled Regulations for In Vivo Radiopharmaceutical...[ Price : $8.95]
Federal Register notices: FDA posts four announcements about a priority review voucher being redeemed as part of a product approva...[ Price : $8.95]
CDRH says its Office of Strategic Partnerships and Technology Innovation has been elevated to a super office.[ Price : $8.95]
A Lilly subsidiary says its investigational gene therapy for some genetic hearing loss showed positive results in a Phase 1/2 tria...